Financhill
Back

Chesapeake Energy Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
10

CHK
Chesapeake Energy

Last Price:
82.46
Seasonality Move:
14.68%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
10
Chesapeake Energy (CHK) is a Sell

Is Chesapeake Energy a Buy, Sell or Hold?

  • The current Chesapeake Energy [CHK] share price is $83.95. The Score for CHK is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • CHK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CHK Stock Price Chart

What is Chesapeake Energy's stock price today?

  • The Chesapeake Energy share price today is $83.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHK is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

CHK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.26 Sell
Relative Strength Index (14 RSI): 30.03 Sell
Chaikin Money Flow: 4230 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.43 - 91.09) Sell
Bollinger Bands (100): (80.98 - 90.32) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

CHK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.06 Sell
20-day SMA: 88.14 Sell
50-day SMA: 88.74 Sell
200-day SMA: 83.84 Buy
8-day EMA: 85.66 Sell
20-day EMA: 87.36 Sell
50-day EMA: 87.74 Sell
200-day EMA: 84.92 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Chesapeake Energy Earnings Growth & CHK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.38 per share, an increase next quarter of $0.77 per share, a decrease this year of $3.16 per share, and an increase next year of $4.89 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Chesapeake Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):